About Genedrive
Genedrive is a company based in Manchester (United Kingdom) founded in 2000 by Christopher Potten and Catherine Booth. Genedrive offers products and services including Genedrive System, Genedrive MT-RNR1 ID Kit, and Genedrive CYP2C19 ID Kit. Genedrive operates in a competitive market with competitors including Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
- Headquarter Manchester, United Kingdom
- Founders Christopher Potten, Catherine Booth
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genedrive Plc
-
Annual Revenue
$1.05 M (USD)130.12as on Jun 30, 2025
-
Net Profit
-$7.16 M (USD)26.06as on Jun 30, 2025
-
EBITDA
-$7.53 M (USD)-5.14as on Jun 30, 2025
-
Latest Funding Round
$1.59 M (USD), Post-IPO
Apr 01, 2025
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Genedrive
Genedrive is a publicly listed company on the LSE with ticker symbol GDR in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Genedrive
Genedrive offers a comprehensive portfolio of products and services, including Genedrive System, Genedrive MT-RNR1 ID Kit, and Genedrive CYP2C19 ID Kit.
Platform for rapid molecular testing of pathogens and variants
Test to detect gene variant preventing antibiotic-induced hearing loss
Rapid test for CYP2C19 genotyping to inform treatment decisions
People of Genedrive
Unlock access to complete
Funding Insights of Genedrive
Investments & Acquisitions by Genedrive
Investment portfolio details for Genedrive
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genedrive
Detailed financials for Genedrive
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genedrive Comparisons
Peer comparison for Genedrive
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genedrive
Genedrive operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
Detailed competitors of Genedrive
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genedrive
Complete news archive for Genedrive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genedrive
Genedrive was founded in 2000 and raised its 1st funding round 18 years after it was founded.
Genedrive is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
James Cheek is the current CEO of Genedrive.
Annual revenue of Genedrive is $1.05M as on Jun 30, 2025.
Genedrive was established in 2000 in Manchester, United Kingdom, within the molecular diagnostics sector. A platform for point-of-care genotyping and sequence analysis is operated, focusing on pharmacogenetic and infectious disease screening. The MT-RNR1 ID Kit is supplied as a test to identify risks of antibiotic-induced deafness in infants. The Genedrive HCV ID Kit is utilized for hepatitis C detection and COVID-19 screening in clinical settings.
Genedrive's top competitors include Visby Medical, Inflammatix and Prenetics.
Genedrive offers Genedrive System, Genedrive MT-RNR1 ID Kit, and Genedrive CYP2C19 ID Kit.
Yes, Genedrive is publicly traded on LSE under the ticker symbol GDR.
The ticker symbol of Genedrive is GDR on LSE.